David Vilkas
Cardiovascular Disease · Woodbury, NYNPI 1912946344
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Johnson & Johnson at 27.3% of the total.
Across 144 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$862
- Novartis$450
- Amgen$408
- Merck$271
- Pfizer$180
- Boehringer Ingelheim$166
- plus $814 from 14 others
What the payments were for
- Food & beverage$3,151100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 37 | $862 |
| Novartis | 25 | $450 |
| Amgen | 18 | $408 |
| Merck | 13 | $271 |
| Pfizer | 8 | $180 |
| Boehringer Ingelheim | 6 | $166 |
| Boston Scientific | 6 | $131 |
| Lexicon Pharmaceuticals, Inc. | 6 | $115 |
| Scpharmaceuticals Inc. | 3 | $81 |
| E.r. Squibb & Sons, L.L.C. | 4 | $73 |
| Alnylam Pharmaceuticals Inc. | 3 | $72 |
| Kestra Medical Technology Services, Inc. | 2 | $65 |
| AstraZeneca | 3 | $65 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Philips North America LLC | 2 | $48 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| GSK | 1 | $19 |
| Gilead | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$3,151 in reported general payments places this provider in the 60th percentile of 2,302 cardiovascular disease providers in New York.
Other cardiovascular disease in Woodbury
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
- Ronald DagostinoLake Success$782K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.